Delivery Order SPE2DR25D1002-SPE2DR26FGN5V
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,100.64 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count unit dose packaging) with a completion date of January 9, 2026. This firm fixed-price, non-competitive delivery order was awarded on January 8, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $16.8K to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract was executed on February 4, 2026, with completion scheduled for February 5, 2026, and is structured under a firm fixed-price arrangement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $6,519.84 for TRIUMEQ 600-50-300 mg tablets in quantities of 30, with a firm fixed price contract type. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) valued at $6,519.84 under a Firm Fixed Price contract type. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30s. This contract, valued at $24,776.99, represents a firm fixed-price delivery order with an ultimate completion date of December 19, 2025. The award was competitively made with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order and...
- The Defense Logistics Agency awarded a $19,605.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets in quantities of 30s, with a completion date of September 29, 2025. This is a non-set-aside competitive award issued to the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal contract portfolio supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $17,386.42 to AmerisourceBergen Drug Corp for 30-unit supplies of Triumeq 600-50-300 mg tablets. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of October 21, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, allowing AmerisourceBergen to compete directly against other qualified pharmaceutical suppliers for this...
- The Defense Logistics Agency awarded a $7,217.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of TRIUMEQ 600-50-300 mg tablets, with an ultimate completion date of September 24, 2025. This non-set-aside competitive award was issued on September 23, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $33,210.45 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. The contract employs firm fixed pricing and is classified as a non-set-aside competitive award, with an ultimate completion date of August 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $23,257.91 to AmerisourceBergen Drug Corp for 30-unit supplies of TRIUMEQ 600-50-300 mg tablets. This contract is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGN5VDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,585.52 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets (30-unit packages) with a completion date of February 5, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order operates under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, covering specialty medications, brand-name and generic drugs, vaccines, and various medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 2/3/26 |